학술논문

Efficacy of Guselkumab in Patients With Moderately to Severely Active Crohn's Disease Not in Clinical Response at Week 12: Results From the GALAXI 1 Study
Document Type
Journal
Source
AMERICAN JOURNAL OF GASTROENTEROLOGY; OCT 2023, 118 10, pS626-pS626, 1p. Supplement: S
Subject
Language
English
ISSN
15720241